Total Payments
$126,341
2024 Payments
$45,543
Companies
24
Transactions
201
Medicare Patients
1,399
Medicare Billing
$201,550
Payment Breakdown by Category
Consulting$106,428 (84.2%)
Other$11,229 (8.9%)
Food & Beverage$4,504 (3.6%)
Travel$2,235 (1.8%)
Research$1,871 (1.5%)
Education$73.71 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $106,428 | 34 | 84.2% |
| Honoraria | $9,803 | 12 | 7.8% |
| Food and Beverage | $4,504 | 124 | 3.6% |
| Travel and Lodging | $2,235 | 9 | 1.8% |
| Unspecified | $1,871 | 16 | 1.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,426 | 3 | 1.1% |
| Education | $73.71 | 3 | 0.1% |
Payments by Type
General
$124,470
185 transactions
Research
$1,871
16 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kedplasma LLC | $106,000 | 33 | $0 (2024) |
| Rhythm Pharmaceuticals, Inc. | $10,540 | 23 | $0 (2024) |
| ABBVIE INC. | $2,324 | 33 | $0 (2024) |
| Madrigal Pharmaceuticals | $2,054 | 7 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $1,553 | 11 | $0 (2023) |
| Novo Nordisk Inc | $882.11 | 36 | $0 (2024) |
| Amgen Inc. | $736.56 | 20 | $0 (2024) |
| Allergan, Inc. | $570.02 | 3 | $0 (2021) |
| Lilly USA, LLC | $183.00 | 10 | $0 (2024) |
| Echosens North America, Inc. | $176.70 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,543 | 71 | Kedplasma LLC ($38,400) |
| 2023 | $44,629 | 71 | Kedplasma LLC ($38,400) |
| 2022 | $33,000 | 41 | Kedplasma LLC ($29,200) |
| 2021 | $2,998 | 16 | Rhythm Pharmaceuticals, Inc. ($2,066) |
| 2019 | $124.99 | 1 | SANOFI-AVENTIS U.S. LLC ($124.99) |
| 2018 | $45.87 | 1 | PFIZER INC. ($45.87) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 12/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $152.75 | General |
| Category: Endocrinology | ||||||
| 11/29/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 11/21/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $278.72 | General |
| Category: LIVER DISEASE | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $233.67 | General |
| Category: LIVER DISEASE | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $108.26 | General |
| Category: LIVER DISEASE | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | Cash or cash equivalent | $40.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Honoraria | Cash or cash equivalent | $428.00 | General |
| Category: Genetic Disease | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Biological | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/02/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $77.00 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Obesity | ||||||
| 09/30/2024 | Kedplasma LLC | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 09/26/2024 | Rhythm Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $428.00 | General |
| 09/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: LIVER DISEASE | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 09/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $122.45 | General |
| Category: Cardiology | ||||||
| 09/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism | ABBVIE INC. | $1,871 | 16 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 293 | 397 | $139,831 | $32,860 |
| 2022 | 10 | 342 | 595 | $148,380 | $49,750 |
| 2021 | 8 | 354 | 521 | $251,899 | $55,696 |
| 2020 | 7 | 410 | 489 | $271,406 | $63,243 |
Total Patients
1,399
Total Services
2,002
Medicare Billing
$201,550
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 109 | $22,345 | $8,567 | 38.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 59 | $56,742 | $7,164 | 12.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $14,250 | $5,604 | 39.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 45 | $11,925 | $5,493 | 46.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 44 | $26,369 | $3,947 | 15.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 14 | $5,740 | $847.56 | 14.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 24 | 24 | $1,200 | $550.85 | 45.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $900.00 | $404.16 | 44.9% |
| 0358T | Whole body composition tissue and fluid measurements with interpretation and report | Office | 2023 | 33 | 39 | $360.00 | $282.24 | 78.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 85 | 202 | $32,211 | $13,375 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 84 | $17,220 | $7,722 | 44.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 51 | $13,515 | $6,773 | 50.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 45 | $44,640 | $6,095 | 13.7% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 49 | 53 | $15,159 | $5,236 | 34.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 27 | 46 | $11,043 | $4,506 | 40.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $9,375 | $3,746 | 40.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 23 | 61 | $3,050 | $1,514 | 49.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 13 | 13 | $1,627 | $530.03 | 32.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 15 | 15 | $540.00 | $253.64 | 47.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 195 | 204 | $202,390 | $29,342 | 14.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 57 | 135 | $15,529 | $9,468 | 61.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 49 | $10,045 | $4,604 | 45.8% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 22 | 33 | $5,403 | $3,389 | 62.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 25 | $6,625 | $2,961 | 44.7% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 25 | 27 | $4,957 | $2,704 | 54.6% |
About Dr. Ryan Morgan, D.O
Dr. Ryan Morgan, D.O is a Internal Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2012. The National Provider Identifier (NPI) number assigned to this provider is 1033454616.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Morgan, D.O has received a total of $126,341 in payments from pharmaceutical and medical device companies, with $45,543 received in 2024. These payments were reported across 201 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($106,428).
As a Medicare-enrolled provider, Morgan has provided services to 1,399 Medicare beneficiaries, totaling 2,002 services with total Medicare billing of $201,550. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Oklahoma City, OK
- Active Since 12/07/2012
- Last Updated 08/13/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1033454616
Products in Payments
- Imcivree (Drug) $6,442
- REZDIFFRA (Drug) $2,038
- ARMOUR THYROID (Drug) $1,783
- IMCIVREE (Drug) $1,564
- Repatha (Biological) $622.75
- BOTOX (Biological) $570.02
- QULIPTA (Drug) $340.16
- Rybelsus (Drug) $212.15
- Wegovy (Drug) $203.02
- Saxenda (Drug) $182.52
- FibroScan (Device) $176.70
- LEQVIO (Drug) $164.74
- DEXCOM G7 GSS (161) (Medical Supply) $152.75
- RYBELSUS (Drug) $147.92
- Ozempic (Drug) $136.50
- NEXLIZET (Drug) $124.99
- PRALUENT (Drug) $124.99
- JARDIANCE (Drug) $123.02
- Zypitamag (Drug) $122.34
- EVKEEZA (Biological) $114.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oklahoma City
John Kingrey, Md, MD
Internal Medicine — Payments: $325,421
Internal Medicine $325,421
Dr. Jeffrey Sparling, M.d, M.D
Internal Medicine — Payments: $289,451
Internal Medicine $289,451
Dr. Romeo Mandanas, M.d, M.D
Internal Medicine — Payments: $275,924
Internal Medicine $275,924
Marcus Smith, Md, MD
Internal Medicine — Payments: $181,269
Internal Medicine $181,269
Usman Baber, Md, MD
Internal Medicine — Payments: $76,000
Internal Medicine $76,000
Dr. Krittapoom Akrawinthawong, M.d, M.D
Internal Medicine — Payments: $74,128
Internal Medicine $74,128